SCHEMBL17355756

SCHEMBL17355756

COC(=O)Oc1cccc(C)c1F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
HPGD P15428 1/20 0.50
HSD17B10 Q99714 1/20 0.50
PTPN1 P18031 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.39
KMT2A Q03164 3/20 0.39
ATM Q13315 2/20 0.39
TDP1 Q9NUW8 1/20 0.39
POLB P06746 2/20 0.37
MAPT P10636 2/20 0.37
LMNA P02545 1/20 0.37
RAB9A P51151 1/20 0.37
KCNK3 O14649 1/20 0.37
KCNK9 Q9NPC2 1/20 0.37
HTT P42858 2/20 0.37
KDM4C Q9H3R0 1/20 0.37
JAK2 O60674 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17355791 0.84 PTPN1 (0.39) KDM4EHPGDHSD17B10PTPN1L3MBTL1
SCHEMBL3342378 0.84 KDM4E (0.43) KDM4EHPGDHSD17B10MAPTLMNA
SCHEMBL1598718 0.81 POLB (0.54) KDM4EHPGDHSD17B10PTPN1L3MBTL1
SCHEMBL17355729 0.81 PTPN1 (0.53) KDM4EHPGDHSD17B10PTPN1L3MBTL1
SCHEMBL1598495 0.81 HPGD (0.61) KDM4EHPGDHSD17B10PTPN1L3MBTL1
SCHEMBL27984902 0.80 KMT2A (0.42) KDM4EHPGDHSD17B10PTPN1L3MBTL1
SCHEMBL13726991 0.78 KDM4E (0.46) KDM4EHPGDHSD17B10KMT2AATM
SCHEMBL17356467 0.78 HPGD (0.46) KDM4EHPGDHSD17B10ATMLMNA
SCHEMBL11925422 0.76 KDM4E (0.70) KDM4EHPGDHSD17B10KMT2AATM
SCHEMBL15454164 0.76 HPGD (0.59) KDM4EHPGDHSD17B10KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE UBE INDUSTRIES, LTD. (JP) 2015-12-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150372349-A1 NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE HCN2, SCO2, HCN1 KDM4E 1067/4885HPGD 2190/4885HSD17B10 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.